Aura Biosciences
AURA
AURA
94 hedge funds and large institutions have $324M invested in Aura Biosciences in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4.67% more ownership
Funds ownership: 74.31% → 78.98% (+4.7%)
1% less capital invested
Capital invested by funds: $329M → $324M (-$4.91M)
94% less call options, than puts
Call options by funds: $16K | Put options by funds: $255K
Holders
94
Holding in Top 10
3
Calls
$16K
Puts
$255K
Top Buyers
1 | +$11.5M | |
2 | +$6.86M | |
3 | +$5.47M | |
4 |
BlackRock
New York
|
+$3.21M |
5 |
![]()
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$970K |
Top Sellers
1 | -$14.2M | |
2 | -$656K | |
3 | -$573K | |
4 |
RCM
Regency Capital Management
Honolulu,
Hawaii
|
-$476K |
5 |
D.E. Shaw & Co
New York
|
-$338K |